Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BABA vs MRNA✓SelectedUSD · MRNABABA vs MRNA performance historyLatest closeAs of-2.63%11/18
Stock and ETF performance explorer

BABA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+14.3%
MRNA return
+156.2%
Excess return
-142.0%
Maximum drawdown
-55.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.6%-4.8%+2.2%-2.5%
7D-16.9%-20.9%+4.0%-16.3%
30D-22.3%-13.3%-9.0%-22.0%
3M-34.2%+212.6%-246.7%-37.5%
6M-36.1%+309.0%-345.1%-41.6%
YTD-41.9%+567.3%-609.2%-50.2%
1Y-46.7%+689.7%-736.4%-55.4%
All+14.3%+156.2%-142.0%+2.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling